isopropyl 2-((6aR,9R)-7-(phenylcarbamoyl)-9-(pyrrolidine-1-carbonyl)-6a,7,8,9-tetrahydroindolo[4,3-fg]quinolin-4(6H)-yl)acetate

ID: ALA1809037

Chembl Id: CHEMBL1809037

PubChem CID: 56663561

Max Phase: Preclinical

Molecular Formula: C31H34N4O4

Molecular Weight: 526.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)OC(=O)Cn1cc2c3c(cccc31)C1=C[C@@H](C(=O)N3CCCC3)CN(C(=O)Nc3ccccc3)[C@@H]1C2

Standard InChI:  InChI=1S/C31H34N4O4/c1-20(2)39-28(36)19-34-17-21-16-27-25(24-11-8-12-26(34)29(21)24)15-22(30(37)33-13-6-7-14-33)18-35(27)31(38)32-23-9-4-3-5-10-23/h3-5,8-12,15,17,20,22,27H,6-7,13-14,16,18-19H2,1-2H3,(H,32,38)/t22-,27-/m1/s1

Standard InChI Key:  RNXRZAYVPFEIRJ-AJTFRIOCSA-N

Associated Targets(Human)

CXCR3 Tchem C-X-C chemokine receptor type 3 (2736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cxcr3 C-X-C chemokine receptor type 3 (96 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cxcr3 C-X-C chemokine receptor type 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.64Molecular Weight (Monoisotopic): 526.2580AlogP: 4.69#Rotatable Bonds: 5
Polar Surface Area: 83.88Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.36CX Basic pKa: CX LogP: 3.73CX LogD: 3.73
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.49Np Likeness Score: -0.67

References

1. Thoma G, Baenteli R, Lewis I, Jones D, Kovarik J, Streiff MB, Zerwes HG..  (2011)  Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.,  21  (16): [PMID:21764306] [10.1016/j.bmcl.2011.06.070]

Source